Journal Article

Meniscal Transplant surgery or Optimised Rehabilitation full randomised trial (MeTeOR2): a study protocol

Haque, Aminul, Stewart, Kimberley, Khan, Iftekhar, Crisford, Peter, Smith, Amy, Myers, P, Parker, David, Parsons, Helen, Smith, Toby, Arnold, Susanne, Guck, Jonathan, Verdonk, Peter, Getgood, Alan, Beard, David, Smith, NA, Underwood, Martin, Price, Andrew James, Milroy, Bryony, Ferreira, Manuela, Ellard, David R, Mason, James, Spalding, Timothy, Bradley, Helen, Metcalfe, Andrew

2024

Overview

IntroductionPain and disability after meniscectomy can be a substantial lifelong problem. There are few treatment options, especially for young people. Non-surgical management (rehabilitation) is an option but increasingly surgeons are performing meniscal allograft transplants (MATs) for these individuals. However, this is still an uncommon procedure, and availability and usage of MAT vary widely both in the UK and internationally. It is not known which treatment option is the most effective and cost-effective.Methods and analysisThe Meniscal Transplant surgery or Optimised Rehabilitation trial is an international, multicentre, randomised controlled trial. The aim is to compare the clinical and cost effectiveness of MAT versus an optimised package of individualised, progressive, rehabilitation that we have called personalised knee therapy (PKT).Participants will be recruited from sites across the UK, Australia, Canada and Belgium. The planned 144 participants provide at least 90% power to detect a 10-point difference in the Knee injury and Osteoarthritis Outcome Score (KOOS4) at 24-months post randomisation (primary outcome). A prospectively planned economic evaluation will be conducted from a healthcare system and personal social services perspective. Secondary outcome data including health utility, occupational status, sports participation, mental well-being, further treatment, and adverse events will be collected at 3, 6, 12, 18, and 24 months. Analysis will be on an intention-to-treat basis and reported in-line with the Consolidated Standards of Reporting Trials statement.Ethics and disseminationThe trial was approved by the London—Bloomsbury Research Ethics Committee on 19 August 2022 (22/LO/0327) and Northern Sydney Local Health District Human Research Ethics Committee, NSW, Australia on the 13 March 2023 (2022/ETH01890).Trial results will be disseminated via peer-reviewed publications, presentations at international conferences, in lay summaries and using social media as appropriate.This protocol adheres to the recommended Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) checklist.Trial registration number ISRCTN87336549.

• Publisher: British Medical Journal Publishing Group,BMJ Publishing Group LTD,BMJ Publishing Group
• Subject: Arthritis / Cost-Benefit Analysis / Humans / Intervention / Knee / Likert scale / Meniscectomy / Menisci, Tibial - surgery / Menisci, Tibial - transplantation / Multicenter Studies as Topic / Osteoarthritis / Pain / Patients / Physical therapy / Pilot projects / Randomized Controlled Trial / Randomized Controlled Trials as Topic / Rehabilitation / REHABILITATION MEDICINE / Surgery / Tibial Meniscus Injuries - rehabilitation / Tibial Meniscus Injuries - surgery / Tibial Meniscus Injuries - therapy / TRANSPLANT SURGERY / Transplants & implants / Well being / Young adults